Ultragenyx Pharmaceutical Inc. - 10-Q Filing

Ultragenyx Pharmaceutical Inc. reports Q3 financial results including revenue from Crysvita, Dojolvi, and Evkeeza products alongside ongoing collaboration royalties.

SEC EDGAR · November 4, 2026, 11:01 UTC

Tickers: $RARE

Read the full article at SEC EDGAR

More Regulatory news

LiveRamp Holdings, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 16:52 UTC
Presurance Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 16:43 UTC
EXPEDITORS INTERNATIONAL OF WASHINGTON INC - 8-K Filing SEC EDGAR · November 12, 2026, 16:42 UTC
AUDIOEYE INC - 10-Q Filing SEC EDGAR · October 26, 2026, 21:11 UTC
ROCKWELL AUTOMATION, INC - 10-K Filing SEC EDGAR · November 12, 2026, 16:35 UTC
United KSK Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 16:29 UTC
AMERICAN SHARED HOSPITAL SERVICES - 8-K Filing SEC EDGAR · November 12, 2026, 16:27 UTC
VIVIC CORP. - 10-K Filing SEC EDGAR · November 12, 2026, 16:26 UTC
WOLVERINE WORLD WIDE INC /DE/ - 10-Q Filing SEC EDGAR · November 12, 2026, 16:24 UTC
BlueOne Technologies, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 16:20 UTC